Search research articles
Contact Us
Filters
Showing results (11-20 of 463) with videos related to
Page
of 47
Sort By:
Gastroenterology
|
June 10, 2006
COX-2 and gastric cancer: More on inflammation and neoplasia
John D Potter, Cornelia M Ulrich
Molecular Nutrition & Food Research
|
April 5, 2013
Folate and health: present and future
Cornelia M Ulrich, Joshua W Miller
JAMA
|
June 7, 2007
Folate and cancer--timing is everything
Cornelia M Ulrich, John D Potter
Future Oncology (London, England)
|
October 14, 2011
Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer?
Adetunji T Toriola, Cornelia M Ulrich
Pharmacogenomics
|
October 7, 2005
Pharmacogenetics of folate-related drug targets in cancer treatment
Kim Robien, Alanna Boynton, Cornelia M Ulrich
Obesity Facts
|
December 14, 2017
Effects of Intentional Weight Loss on Markers of Oxidative Stress, DNA Repair and Telomere Length - a Systematic Review
Caroline Himbert, Henry Thompson, Cornelia M Ulrich
Pharmacogenomics
|
June 8, 2002
Pharmacogenetics and folate metabolism -- a promising direction
Cornelia M Ulrich, Kim Robien, Rachel Sparks
Nature Reviews. Cancer
|
January 27, 2004
Cancer pharmacogenetics: polymorphisms, pathways and beyond
Cornelia M Ulrich, Kim Robien, Howard L McLeod
Nature Reviews. Cancer
|
February 24, 2006
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Cornelia M Ulrich, Jeannette Bigler, John D Potter
Discovery Medicine
|
January 20, 2007
Genetic tools to tailor cancer prevention by NSAIDs
Cornelia M Ulrich, Jeannette Bigler, John D Potter
Page
of 47
Search research articles
Search
Showing results (11-20 of 463) with videos related to
Sort By:
Page
of 47
Gastroenterology
|
June 10, 2006
COX-2 and gastric cancer: More on inflammation and neoplasia
John D Potter, Cornelia M Ulrich
Molecular Nutrition & Food Research
|
April 5, 2013
Folate and health: present and future
Cornelia M Ulrich, Joshua W Miller
JAMA
|
June 7, 2007
Folate and cancer--timing is everything
Cornelia M Ulrich, John D Potter
Future Oncology (London, England)
|
October 14, 2011
Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer?
Adetunji T Toriola, Cornelia M Ulrich
Pharmacogenomics
|
October 7, 2005
Pharmacogenetics of folate-related drug targets in cancer treatment
Kim Robien, Alanna Boynton, Cornelia M Ulrich
Obesity Facts
|
December 14, 2017
Effects of Intentional Weight Loss on Markers of Oxidative Stress, DNA Repair and Telomere Length - a Systematic Review
Caroline Himbert, Henry Thompson, Cornelia M Ulrich
Pharmacogenomics
|
June 8, 2002
Pharmacogenetics and folate metabolism -- a promising direction
Cornelia M Ulrich, Kim Robien, Rachel Sparks
Nature Reviews. Cancer
|
January 27, 2004
Cancer pharmacogenetics: polymorphisms, pathways and beyond
Cornelia M Ulrich, Kim Robien, Howard L McLeod
Nature Reviews. Cancer
|
February 24, 2006
Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics
Cornelia M Ulrich, Jeannette Bigler, John D Potter
Discovery Medicine
|
January 20, 2007
Genetic tools to tailor cancer prevention by NSAIDs
Cornelia M Ulrich, Jeannette Bigler, John D Potter
Page
of 47